China Pharma Holdings
CPHI
6 hedge funds and large institutions have $15.7K invested in China Pharma Holdings in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.07% less ownership
Funds ownership: 0.58% → 0.51% (-0.07%)
56% less capital invested
Capital invested by funds: $35.4K → $15.7K (-$19.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10.9K |
| 2 |
Citigroup
New York
|
+$837 |
| 3 |
Renaissance Technologies
New York
|
+$84 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$21.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$104 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $7.88K | +$10.9K | +12,924 | New |
|
|
2
Renaissance Technologies
New York
| $6.96K | +$84 | +100 | +0.9% |
|
|
3
Citigroup
New York
| $608 | +$837 | +996 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $237 | -$104 | -124 | -24% |
|
|
EI
5
EFG International
Zurich,
| $24 | – | – | – |
|
|
DB
6
Danske Bank
Copenhagen K,
Denmark
| $1 | – | – | – |
|
|
DS
7
DRW Securities
Chicago,
Illinois
| – | -$21.1K | -17,423 | Closed |
|
CPHI Hedge Fund Activity: Q1 2026 in Review
6 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2026, worth a combined $15.7K — down 56% from $35.4K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CPHI positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $10.9K. The largest seller was DRW Securities, exiting entirely with an estimated $21.1K sold.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q1 2026, up from 5 in Q4 2025.
- Funds reported $15.7K of China Pharma Holdings stock for Q1 2026, down 56% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q1 2026 and 1 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q1 2026 was Citadel Advisors, an estimated $10.9K added.
- The largest China Pharma Holdings seller in Q1 2026 was DRW Securities, an estimated $21.1K sold.
Based on aggregated 13F filings for Q1 2026.